ArticleMedicine, health care, and philosophy2026
The academic theatre of shadows: epistemological and ethical erosion in the era of marketing-based medicine.
Article in Medicine, health care, and philosophy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper analyzes the systemic crisis within contemporary medical academia, characterized by the authors as the "Academic Theatre of Shadows." This phenomenon occurs when the epistemological rigor of Evidence-Based Medicine (EBM) is superseded by Evidence-Based Marketing (EBM-m). The study examines how modern academic institutions consciously or unconsciously facilitate an environment where charismatic med-influencers prioritize digital metrics, public relations, and commercial viability over physiological accuracy, patient safety, and methodological validation. By deconstructing the mechanism of "commodity diagnostics"-specifically analyzing the misinterpretation of Cross-reactive Carbohydrate Determinants (CCDs) as a prime case study-the article highlights how analytical errors are deliberately rebranded as scientific discoveries. This process creates an ethical hazard by pathologizing healthy populations for commercial gain, transforming citizens into "phantom patients." Furthermore, the paper explores the sociological "Inversion of Hierarchy," drawing parallels with the Theranos scandal, to demonstrate how administrative support for marketing-driven agendas marginalizes expert epistemic authority. The article concludes by utilizing the frameworks of agnotology and communicative action to analyze institutional complicity, ultimately advocating for a radical return to epistemic responsibility and the ethical foundations of the university as an uncompromising guardian of scientific truth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.